@savadMG Profile picture

M G.Savad

@savadMG

Husband, Father, Son, MD, MSc, RadOnc

Joined April 2018
Similar User
Anupam Rishi photo

@RishiA_MD

Koko photo

@kokinioRT

Ogorodniitchouk photo

@Dr_Oleksandr_O

Mohammad Hasan photo

@MohammadHasanMD

Nima Harandi photo

@nimaharandimd

Kuan-Wen Chen photo

@ymouch

Ramesh Pandey photo

@Ramesh_Pandey_

Robbe Van den Begin photo

@Van_den_Begin

Sam Regan photo

@SamReganMD

Naoual Oulmoudne photo

@NaoualO

karine campagnolo photo

@karinecampagno5

M G.Savad Reposted

Completely agree. I also wish we had more funding for benign conditions. We really need to expand our denominator. For example, how can we secure funding for ultra-low dose RT in patients with R/R multiple sclerosis, with a primary endpoint of reducing systemic therapy…


M G.Savad Reposted

🚨 Randomized Trial OS benefit Low Grade Glioma w/TMZ 🚨

Tweet Image 1

M G.Savad Reposted

In 1922, a group of scientists went to the Toronto General Hospital where diabetic children were kept in wards, often 50 or more at a time. Most of them were comatose and dying from diabetic ketoacidosis. Others were being treated by being placed on an extremely strict diet,…

Tweet Image 1

M G.Savad Reposted

🇬🇧🇬🇧 D-Day hero George Chandler was due to march past the Cenotaph this Remembrance Sunday, but sadly passed away on 19 October. His granddaughters upheld his wishes to be present at this year’s parade, and marched in honour of him. 🌺❤️ Source: BlindVeteransUK

Tweet Image 1

M G.Savad Reposted

Of >26K cancer trials, only 3.5% evaluated RT, 3% device, 4.5% procedure; majority drugs While I’ve focused mostly on RT, research across local modalities disproportionately low W expanding indications & new tech, local tx need/ deserve approp vetting! ascopubs.org/doi/10.1200/JC…

Tweet Image 1

M G.Savad Reposted

In a distracted world, the most underrated leadership skill is listening. 144 studies, 155k people: Good listeners have deeper bonds and better results. We feel valued, and they get smarter. Great leaders are devoted learners. A key to learning is to listen more than you talk.

Tweet Image 1

M G.Savad Reposted

Dear @Humana, my patient with oligometastatic prostate cancer (CHAARTED-defined) qualifies for prostate-directed radiotherapy per STAMPEDE Arm H—a Phase III trial showing overall survival benefit. Despite 3D radiotherapy approval, IMRT was denied. I was denied peer-to-peer review…


M G.Savad Reposted

We’re oncologists and should be called radiation oncologists. I feel very strongly about this as in my early professional life, I was being trained in clinical oncology (combined rad and med onc via @RCRadiologists ).


M G.Savad Reposted

Must read clinical trials in the field of #SBRT 2024 Please complement the list, to allow us staying up-to-date !

Tweet Image 1
Tweet Image 2

M G.Savad Reposted

"Oligo"-no more! 🇨🇦ARREST phase I out now @IJROBP - @sueyom ➡️SABR to median=16 "poly"metastases in patients who had already exhausted multiple lines of systemic therapy ➡️4x dose levels (up to 6Gyx5). ➡️No safety signals, QoL maintained. shorturl.at/gStwt Congrats! 👏👏

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

M G.Savad Reposted

We started with 144 inventions and through several rounds and 400,000 votes, there is a winner! Canada's Greatest Invention is...INSULIN!! Canada's Favourite Roadside Attraction poll contest starts tomorrow. 448 roadside attractions to choose from!


M G.Savad Reposted

Today we remember those who have fallen, who made the ultimate sacrifice and gave their lives for our freedom. May their memory forever live on. #LestWeForget


M G.Savad Reposted

On this Remembrance Day, we pause to honor the courage and sacrifices of the men and women who served, and continue to serve our nation. We remember those who gave their lives and those who continue to live with the lasting impact of their service. Lest we forget.

Tweet Image 1

M G.Savad Reposted

I WANT TO WORK WITH YOU!!!. The level of participation in an election represents the health of an organization. ACRO has multiple board position up for election in coming cycle. Please consider running for office. The process is detailed in link below. Any questions, DM or call…

Tweet Image 1
Tweet Image 2

M G.Savad Reposted

Ever wondered why the white ribbon represents lung cancer? White symbolizes breath, essential to lung health. The ribbon creates unity and solidarity in the fight against lung cancer. Wear it, share it, spread awareness. Let’s breathe hope together. 🌬️ #LungCancerAwareness

Tweet Image 1

M G.Savad Reposted

My dad died just 3 months after he was diagnosed with #LungCancer. My mom died only 6 months after her diagnosis. I’ve now lived with lung cancer for 15 years—a gift made possible by advancements in research that gave me options my mom and dad never had. But we can’t stop here.…

As @jillfeldman4 says, #research is not just about science. It’s about people. About giving them a chance. Jill’s personal story is hard to fathom and illustrates why it’s so important to her that research bring every person and family a chance. #BecauseofResearch #LCAM



M G.Savad Reposted

Sharing our NRG pancreas contouring atlas - now in press! Target volume delineation for dose-escalated RT in pancreas cancer has been highly variable, making it difficult to rigorously assess the efficacy and toxicity of RT. redjournal.org/article/S0360-… 1/13


M G.Savad Reposted

Our #breastcancer study, NRG-BR009 OFSET, is trying to determine if the chance of breast cancer returning would be less if chemotherapy is added to hormonal therapy w/an aromatase inhibitor & ovarian function suppression. Overview webinars: conta.cc/3U3KbKE

Tweet Image 1

M G.Savad Reposted

Low Dose Radiotherapy, it is wonderful to get these messages in the patient portal:

Tweet Image 1

M G.Savad Reposted

Dose constraints in #radiotherapy #BreastCancer ⛔️ all OARs ☢️ different fractionation schedules 🩺 proposed DVCs correlated with clinical endpoints #RadOnc for a 50 days' free access 👇🏼 authors.elsevier.com/c/1j-vNcA0-Idri

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.